Results 271 to 280 of about 21,384 (315)
Co-Delivery of Multiple Toll-Like Receptor Agonists and Avian Influenza Hemagglutinin on Protein Nanoparticles Enhances Vaccine Immunogenicity and Efficacy. [PDF]
Adv Healthc MaterRamirez A +6 more
europepmc +1 more source
Adjuvant-Induced Autoimmune Syndrome: A Bibliometric Analysis. [PDF]
CureusOspina-Gómez JE +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
DDA as an immunological adjuvant
Research in Immunology, 1992As compared to other adjuvants, DDA is a moderate or strong adjuvant for humoral responses and a strong adjuvant for CMI, especially DTH responses, against different types of antigens and in both laboratory animals and larger animals. DDA can collaborate with other immunomodulating compounds resulting in further enhanced responses.
H. Snippe, L.A.T. Hilgers
openaire +3 more sources
Lithium as an immunologic adjuvant
Medical Hypotheses, 1980Lithium, an adenylate cyclase inhibitor, stimulates a variety of in vitro indices of immune function, including proliferation of lymphocytes in response to mitogens, rosette formation by T-cells and phagocytosis by macrophages. Lithium enhances these immunologic responses at concentrations comparable to those achieved in patients receiving lithium for ...
William Borkowsky +2 more
openaire +3 more sources
Comparison of immunological adjuvants
APMIS, 2019In this study, several innate immunological adjuvants and related compounds were compared with respect to complement activation in serum and induction of cytokine release in whole blood samples using immunoassays. As found, simple lipids had no effect on the complement system or on cytokine release, whereas lipopolysaccharides induced prominent release
Kristin Skogstrand +5 more
openaire +3 more sources
Cytokines as immunological adjuvants
Vaccine, 1992Various cytokines have been shown to be effective immunological adjuvants in a variety of model systems, enhancing protection induced by viral, bacterial and parasitic vaccines, and increasing parameters of immunity in tumour immunization models and in clinical trials.
A.W. Heath, J.H.L. Playfair
openaire +3 more sources
Recombinant cytokines as immunological adjuvants
Immunology & Cell Biology, 1993SummaryThis paper describes the bacterial expression and purification of bioactive recombinant ovine interleukin‐2 (rovIL‐2), interleukin‐lα (rovlL‐lα) and tumour necrosis factor α. These purified proteins had specific activities in appropriate bioassays of 1 × 107, 1 times; 107 and 1 × 105 U/mg, respectively.
Nash, AD +7 more
openaire +4 more sources
Current Status of Immunological Adjuvants
Annual Review of Immunology, 1986Sixty years ago Ramon demonstrated that it was possible to augment the antitoxin response to diphtheria and tetanus by administering vaccines with pyogenic bacteria or with various additional compounds (1). Since that time, clinicians and immunologists have sought to potentiate the immune response with adjuvants while attempting to minimize the often ...
H S Warren, F R Vogel, L A Chedid
openaire +3 more sources
Immunology of Vaccine Adjuvants
2009In recent times vaccine adjuvants, or immunopotentiators, received abundant attention in the media as critical ingredients of current and future vaccines. Indeed, vaccine adjuvants are recognized to make the difference between competing vaccines based on identical antigens.
Ribeiro, C.M.S., Schijns, V.E.J.C.
openaire +3 more sources
ChemInform Abstract: GLYCOLIPIDS AS POTENTIAL IMMUNOLOGIC ADJUVANTS
Chemischer Informationsdienst, 1980AbstractAus der Tri‐O‐acetyl‐thiofucopyranose (I) erhält man mit Bromiden oder Iodiden in Gegenwart von Triethylamin oder 1,5‐Diazabicyclo(5,4,0)undecen‐(5) die Thioether (II), von denen die meisten in ihrer Aktivität mit N‐Acetyl‐muramyl‐L‐alanyl‐D‐isoglutamin vergleichbar sind.
Tsung-Ying Shen +3 more
openaire +4 more sources